Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
HANOVER, N.H. (AP) — A research team at Dartmouth's Geisel School of Medicine is getting $5.3 million to study medication-assisted treatment for pregnant women with opioid use disorders.
Officials say combining medication with psychosocial services has been shown to significantly reduce poor outcomes for babies born to mothers with opioid use disorders, but it can be difficult for women to find providers. In northern New England, 5 to 8 percent of newborns have mothers with such disorders.
The team will compare whether integrated care models, where women receive both maternity care and addiction treatment in the same practice, are more effective than providing such treatment in different locations.
The five-year award comes from the Patient-Center Outcomes Research Institute.
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
